| 000 | 01581 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515025941.0 | ||
| 264 | 0 | _c20071026 | |
| 008 | 200710s 0 0 eng d | ||
| 022 | _a1744-7666 | ||
| 024 | 7 |
_a10.1517/14656566.7.8.1041 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGradishar, William J | |
| 245 | 0 | 0 |
_aAlbumin-bound paclitaxel: a next-generation taxane. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cJun 2006 |
||
| 300 |
_a1041-53 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 | _aAlbumin-Bound Paclitaxel |
| 650 | 0 | 4 |
_aAlbumins _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aEndothelial Cells _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycerol _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intra-Arterial |
| 650 | 0 | 4 | _aNanotechnology |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aOsteonectin _xmetabolism |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aSolvents _xtoxicity |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 7 _gno. 8 _gp. 1041-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656566.7.8.1041 _zAvailable from publisher's website |
| 999 |
_c16320445 _d16320445 |
||